---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-046136"
form_type: "8-K"
ticker: "PCRX"
cik: "0001396814"
company_name: "Pacira BioSciences, Inc."
filed_at: "2026-06-30T11:31:57+00:00"
generated_at: "2026-06-30T11:35:07.305368+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Pacira divests iovera business to Zimmer Biomet for up to $140M

## Summary
- Upfront payment of $70M; potential milestone payments up to $70M through 2031.
- 66 employees (~8% of workforce) expected to be hired by Zimmer Biomet at close.
- Pacira to use net proceeds to pay down senior secured revolving credit facility.
- Parties to collaborate on advancing spasticity program; incremental compensation possible.
- Transaction expected to close in Q3 2026, subject to customary conditions.

## SEC filing metadata
- accession: 0001628280-26-046136
- form_type: 8-K
- ticker: PCRX
- cik: 0001396814
- company_name: Pacira BioSciences, Inc.
- filed_at: 2026-06-30T11:31:57+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1396814/000162828026046136/0001628280-26-046136-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1396814/000162828026046136/pcrx-20260628.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-046136
- JSON: https://secwatch.observer/filing/0001628280-26-046136.json
- Plain text: https://secwatch.observer/filing/0001628280-26-046136.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.